Clinical trial · Observational
Study to Evaluate the Safety of Nanoxel M Inj.
An Observational Study to Evaluate the Safety of Nanoxel M (Docetaxel-PM) Inj.
NCT04066335CI-TRIAL-00042414unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study to evaluate the safety of Nanoxel M inj. administration in patients.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Safety of Nanoxel M inj.
- timeFrame
- through study completion, an average of 6cycles(each cycle is 3weeks)
- description
- The incidence of Treatment-Emergent Adverse Event
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults ≥18 years old 2. Patients who have signed written consent form prior to participating in the clinical trial 3. Patients who are assessed as adequate to administer Nanoxel M injection. Exclusion Criteria: 1\) Patients who have shown severe hypersensitivity to Docetaxel and concomitant drugs
References
Publications (0)
Data not yet available
No reference posted for this study.